Search
for

    Sort by

    Research 331–360 of 1000+

    1. Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports Dove Medical Press (Taylor and Francis Group) · 2026
    2. Stem cell-based therapies for alopecia areata: a narrative review Stem Cell Research & Therapy · 2026
    3. MODERN BIOLOGICAL TREATMENT METHODS FOR ALOPECIA AREATA: A COMPREHENSIVE REVIEW International Journal of Innovative Technologies in Social Science · 2026
    4. Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies Biomedicines · 2025
    5. A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata. PubMed · 2025
    6. Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib Frontiers in Medicine · 2025
    7. Intrinsic Modulators of Hair Growth: Roles of Growth Factors, Cytokines, Chemokines, and Interferons International Journal of Trichology · 2025
    8. Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata Frontiers in Pharmacology · 2025
    9. Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report Frontiers in Immunology · 2025
    10. Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle Frontiers in Medicine · 2025
    11. Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata Dermatologic Therapy · 2025
    12. Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis Clinical Cosmetic and Investigational Dermatology · 2025
    13. Non-Scarring Alopecia in Females: A Comprehensive Review EMJ Dermatology · 2024
    14. Safety and efficacy of tofacitinib in 97 alopecia areata patients Journal of cosmetic dermatology · 2024
    15. Immune niches for hair follicle development and homeostasis Frontiers in physiology · 2024
    16. A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis Indian Dermatology Online Journal · 2023
    17. Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis Skin Research and Technology · 2023
    18. Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome Dermato · 2023
    19. New Drugs for Alopecias 2019
    20. Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers 2021 · 36 citations
    21. Novel potential therapeutic targets of alopecia areata Frontiers in Immunology · 2023 · 1 citations
    22. Systemic Therapies for Scarring and Non-scarring Alopecia 2017 · 1 citations
    23. Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib Frontiers in Medicine · 2023
    24. Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report Frontiers in Pediatrics · 2024
    25. Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience The Journal of Dermatology · 2025
    26. JAK inhibition decreases the autoimmune burden in Down syndrome eLife · 2024 · 18 citations
    27. Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients Acta Dermato Venereologica · 2025
    28. Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation Genes & Development · 2014 · 40 citations
    29. When hair dig into the brain, JAKi , may help! Journal of the European Academy of Dermatology and Venereology · 2026
    30. Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy JAAD Case Reports · 2023 · 7 citations